Date of management change: January 14, 2017
Columbus, OH-based Appointed Michael Triplett as Co Founder, President and Chief Executive Officer
Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first-ever, corrective treatments for Limb-girdle muscular dystrophy.
Michael Triplett is Founder and Co Founder, President and Chief Executive Officer at Myonexustx . Previously, Michael held various senior HR leadership roles in the industry.
News
Short ProfileName: Michael Triplett
Title: Co Founder, President and Chief Executive Officer
Company: Myonexustx
Industry: Pharmaceuticals
Current Contact InfoEmail: ****************@myonexustx.com
Phone:.***.*77
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Brown Robert, Kaiser Rachel, Lee James, Clohisey Debra, Nielsen Peter, Kramer Stephanie, Edelman Kerry, Frymire Michelle, McAlexander Wallace, Griffiths Francis, Hillmer Carol
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
